apZme Launches AI-Powered Home Sleep Testing Device to Revolutionize Sleep Apnea Diagnosis
TL;DR
apZme Dx offers a modern, convenient way to conduct home sleep tests, giving an advantage to those seeking hassle-free sleep diagnostics.
apZme Dx is a wrist-worn type IV testing device that uses familiar pulse oximeters and AI-driven analysis to detect respiratory events and identify sleep stages.
The launch of apZme Dx represents a commitment to advancing sleep health, delivering high-quality, patient-centered care for improved patient outcomes and quality of life.
apZme Dx, a new type IV home testing device and AI-powered mobile app, simplifies and accelerates the identification, diagnosis, and treatment of sleep-disordered breathing disorders like sleep apnea.
Found this article helpful?
Share it with your network and spread the knowledge!
apZme, a leader in dental sleep medicine, has launched apZme Dx, a new type IV home testing device and AI-powered mobile app developed in collaboration with Millennium Sleep Lab, an apZme company. The wrist-worn device uses signals from pulse oximeters and employs advanced AI-driven analysis to accurately detect respiratory events including AHI, RDI, and hypoxic burden while identifying sleep stages such as wake, light sleep, deep sleep, and REM.
The comprehensive data provides clinicians with a fuller evaluation of sleep health, and the app immediately transfers data for physician review, allowing clinicians to access and interpret information with ease while exporting final sleep reports for sleep apnea diagnosis and treatment. Rani Ben-David, Founder and CEO of apZme, stated that the company's mission is to lead innovation in dental sleep medicine and bring accessible, effective sleep health solutions to patients everywhere through this technological advancement.
The app's features are designed to ensure inclusivity and accuracy with no performance bias related to skin color, making it effective for diverse patient populations. The platform also centralizes data management across multiple devices, creating a streamlined process for clinicians and enabling multi-night testing to provide a comprehensive picture of patient sleep patterns. Dr. Kent Smith, DDS, D-ABDSM, CEO of Star Sleep & Wellness, and Co-Founder & President of apZme, emphasized that the launch represents apZme's commitment to advancing sleep health through centralized device data, easier clinician access, and accelerated treatment delivery.
Jeff Scholtes, CEO of Millennium Sleep Lab, an apZme company, added that the release underscores apZme's pursuit of innovation as they continue to lead the field in dental sleep medicine. The technology aims to transform sleep health diagnostics by making them easier, faster, and more convenient than traditional methods, ultimately improving patient outcomes and quality of life through advanced technological solutions. Learn more at https://www.apzme.com and https://www.millenniumsleeplab.com.
Curated from 24-7 Press Release
